Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclobutane pyrimidine dimers (CPDs) are DNA lesions formed when two adjacent pyrimidine bases on the same DNA strand become covalently linked via a cyclobutane ring. This is primarily induced by UV radiation, distorting the DNA helix and blocking essential cellular processes such as replication and transcription. If unrepaired, CPDs can result in mutations that contribute significantly to skin disorders—including sunburn—and are major drivers of UV-induced skin cancers such as melanoma.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclobutane Pyrimidine Dimer (CPD).